Offer - Urjas Oil for just ₹ 1 X
Serenace 0.25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Schizophrenia. Serenace 0.25 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Serenace 0.25 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Serenace 0.25 Mg Tablet can also lead to other problems, which have been listed below. These side effects of Serenace 0.25 Mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Serenace 0.25 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Serenace 0.25 Mg Tablet related warnings talks about Serenace 0.25 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Depression, Arrhythmia, Bradycardia (Slow Heart Rate) must refrain from the use of Serenace 0.25 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Serenace 0.25 Mg Tablet are listed in the contraindications section below.
Additionally, Serenace 0.25 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Serenace 0.25 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Serenace 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Serenace 0.25 Mg Tablet safe for pregnant women?
Serenace may have some side effects during pregnancy. Pregnant women should discontinue the use of Serenace, and talk to their doctor, if they notice any discomfort.
Is the use of Serenace 0.25 Mg Tablet safe during breastfeeding?
Serenace should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Serenace 0.25 Mg Tablet on the Kidneys?
There are no side effects of Serenace on the kidneys.
What is the effect of Serenace 0.25 Mg Tablet on the Liver?
Serenace has very mild side effects on the liver.
What is the effect of Serenace 0.25 Mg Tablet on the Heart?
Side effects of Serenace rarely affect the heart.
Serenace 0.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Serenace 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Serenace 0.25 Mg Tablet habit forming or addictive?
Serenace 0.25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Serenace 0.25 Mg Tablet. So it is best to avoid driving.
Is it safe?
Serenace 0.25 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Serenace 0.25 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Serenace 0.25 Mg Tablet
It is safe to take Serenace 0.25 Mg Tablet with food.
Interaction between Alcohol and Serenace 0.25 Mg Tablet
Consumption of alcohol and Serenace 0.25 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 633-634
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Haldol® (haloperidol)